Quick Takeaways
- MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G/A for ANI Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ANIP).
- Disclosed ownership: 3.8%.
- Date of event: 31 Mar 2025.
MILLENNIUM MANAGEMENT LLC - 31 Mar 2025 SCHEDULE 13G/A Report for ANI Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ANIP)
- Filing Manager
- MILLENNIUM MANAGEMENT LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- ANIP
- Shares outstanding
- 21,535,289 shares
- Disclosed Ownership
- 818,341 shares
- Ownership
- 3.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 10 Apr 2025, 16:00:18 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 21 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MILLENNIUM MANAGEMENT LLC disclosed 3.8% ownership in ANI Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (ANIP) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 21 Jan 2025.
- Current filing was accepted on 10 Apr 2025, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Millennium Management LLC | 3.8% | 818,341 | 0 | 818,341 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 3.8% | 818,341 | 0 | 818,341 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 3.8% | 818,341 | 0 | 818,341 | /s/ Israel A. Englander | Israel A. Englander |